Detalhe da pesquisa
1.
A novel method of multiple nucleic acid detection: Real-time RT-PCR coupled with probe-melting curve analysis.
Anal Biochem
; 537: 50-55, 2017 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28882747
2.
Development of sandwich ELISAs that can distinguish different types of coxsackievirus A16 viral particles.
Appl Microbiol Biotechnol
; 100(6): 2809-15, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26767830
3.
Evaluation of immunity to varicella zoster virus with a novel double antigen sandwich enzyme-linked immunosorbent assay.
Appl Microbiol Biotechnol
; 100(21): 9321-9329, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27629124
4.
A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine.
Appl Microbiol Biotechnol
; 99(11): 4845-53, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25935343
5.
Intranasal influenza-vectored COVID-19 vaccines confer broad protection against SARS-CoV-2 XBB variants in hamsters.
PNAS Nexus
; 3(5): pgae183, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38800610
6.
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
Lancet Infect Dis
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614117
7.
ORF7 of varicella-zoster virus is a neurotropic factor.
J Virol
; 86(16): 8614-24, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674980
8.
Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.
PeerJ
; 11: e15698, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37554334
9.
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial.
Lancet Reg Health West Pac
; 34: 100707, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37283962
10.
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Respir Med
; 11(12): 1075-1088, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979588
11.
A microfluidic system for rapid nucleic acid analysis based on real-time convective PCR at point-of-care testing.
Microfluid Nanofluidics
; 26(9): 69, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35991118
12.
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688558
13.
Development of a skin- and neuro-attenuated live vaccine for varicella.
Nat Commun
; 13(1): 824, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149692
14.
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.
Sci Bull (Beijing)
; 67(13): 1372-1387, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637645
15.
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Lancet Respir Med
; 10(8): 749-760, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644168
16.
A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine.
Hum Vaccin Immunother
; 17(2): 381-388, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750255
17.
Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating.
Cell Host Microbe
; 29(3): 448-462.e5, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539764
18.
Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.
Vaccine
; 39(8): 1241-1247, 2021 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516600
19.
Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids.
Nat Microbiol
; 5(12): 1542-1552, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32895526
20.
Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16.
Cell Host Microbe
; 27(2): 249-261.e5, 2020 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027857